VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (5)
A short sequence within two purine-rich enhancers determines 5' splice site specificity.
Binding of PurH to a muscle-specific splicing enhancer functionally correlates with exon inclusion in vivo.
Early clinical development of epidermal growth factor receptor targeted therapy in breast cancer.
Identification of critical active-site residues in the multifunctional human DNA repair enzyme HAP1.
Metformin use and improved response to therapy in esophageal adenocarcinoma.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Early clinical development of epidermal growth factor receptor targeted therapy in breast cancer.
Early clinical development of epidermal growth factor receptor targeted therapy in breast cancer. Expert Opin Investig Drugs. 2017 Apr; 26(4):463-479.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Breast Neoplasms
Drug Design
Drugs, Investigational
ErbB Receptors
Female
Humans
Molecular Targeted Therapy
Protein Kinase Inhibitors
authors with profiles
NAOTO T UENO